🇺🇸 FDA
Patent

US 11198858

Codon optimized GLA genes and uses thereof

granted A61KA61K48/00A61K48/005

Quick answer

US patent 11198858 (Codon optimized GLA genes and uses thereof) held by 4D MOLECULAR THERAPEUTICS INC. expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
4D MOLECULAR THERAPEUTICS INC.
Grant date
Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K48/00, A61K48/005, A61K48/0066, A61K48/0075